Abstract
In epidemiological cohorts, there is an increased interest for the implementation of biobanks. The potential role of biological determinants of diseases needs to be investigated before the onset of the event of interest in order to limit the problems encountered when examining biological determinants in classical case–control studies. Biobank is now a very sophisticated system that consists of a programmed storage of biological material and related data. Our aim in this paper is to document how biobank constitution is useful for studying biological determinants of aging and to give some indications on methodological issues that can be helpful to optimize the constitution and use of biobanks in aging cohorts. Optimization of sampling through two-phase designs (nested case control or case–cohort studies) allows better efficiency. These elements are, for most of them, not specific to aging populations but are useful more generally for the epidemiology of chronic diseases. Our purpose will be illustrated with some examples and results obtained in an ongoing aging cohort, the Three-City Study.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Artene SA, Ciurea ME, Purcaru SO, Tache DE, Tataranu LG, Lupu M, Dricu A (2013) Biobanking in a constantly developing medical world. Sci World J 2013:343275. doi:10.1155/2013/343275
Barlow WE, Ichikawa L, Rosner D, Izumi S (1999) Analysis of case–cohort designs. J Clin Epidemiol 52:1165–1172
Cambon-Thomsen A, Ducournau P, Gourraud P-A, Pontille D (2003) Biobanks for genomics and genomics for biobanks. Comp Funct Genomics 4:628–634. doi:10.1002/cfg.333
Carcaillon L, Gaussem P, Ducimetiere P, Giroud M, Ritchie K, Dartigues JF, Scarabin PY (2009) Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study. J Thromb Haemost 7:1972–1978. doi:10.1111/j.1538-7836.2009.03603.x
Carcaillon L, Brailly-Tabard S, Ancelin ML, Rouaud O, Dartigues JF, Guiochon-Mantel A, Scarabin PY (2014) High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women. Neurology 82:504–511. doi:10.1212/WNL.0000000000000107
Chatterji S, Byles J, Cutler D, Seeman T, Verdes E (2015) Health, functioning, and disability in older adults present status and future implications. Lancet. doi:10.1016/S0140-6736(14)61462-8
Clement B et al (2014) Public biobanks: calculation and recovery of costs. Sci Transl Med 6:261fs245. doi:10.1126/scitranslmed.3010444
3C Study Group (2003) Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 22:316–325
De Paoli P (2005) Biobanking in microbiology: from sample collection to epidemiology, diagnosis and research. FEMS Microbiol Rev 29:897–910. doi:10.1016/j.femsre.2005.01.005
Doll R (2001) Cohort studies: history of the method II. Retrospective cohort studies. Soz Praventivmed 46:152–160
Elliott P, Peakman TC (2008) The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 37:234–244. doi:10.1093/ije/dym276
Gabelle A et al (2013) Plasma amyloid-beta levels and prognosis in incident dementia cases of the 3-City Study. J Alzheimers Dis 33:381–391. doi:10.3233/JAD-2012-121147
Gabelle A et al (2014) Plasma beta-amyloid 40 levels are positively associated with mortality risks in the elderly. Alzheimers Dement. doi:10.1016/j.jalz.2014.04.515
Henny J, Goldberg M, Zins M (2012) Guide pour la constitution d’une Biobanque associée aux études épidémiologiques en population générale. Inserm-Lavoisier, Tec & Doc, Paris
Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300
Lambert JC et al (2009) Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology 73:847–853. doi:10.1212/WNL.0b013e3181b78448
Langholz B (2005) Case–control study nested. In: Colton PAT (ed) Encyclopedia of biostatistics, vol 1, 2nd edn. Wiley, Chichester, pp 646–655
Langholz B, Thomas DC (1990) Nested case–control and case–cohort methods of sampling from a cohort: a critical comparison. Am J Epidemiol 131:169–176
Lehmann S et al (2014) Impact of harmonization of collection tubes on Alzheimer’s disease diagnosis. Alzheimer’s Dementia. doi:10.1016/j.jalz.2013.06.008
Moulin JJ et al (1998) Lung cancer risk in hard-metal workers. Am J Epidemiol 148:241–248
Noiville C (2012) Biobanks for research. Ethical and legal aspects in human biological samples collections in France. J Int Bioeth 23(165–172):183–264
Prentice RL, Self SG (1988) Aspects of the use of relative risk models in the design and analysis of cohort studies and prevention trials. Stat Med 7:275–287
Reichel J, Lind AS, Hansson MG, Litton JE (2014) ERIC: a new governance tool for biobanking. Eur J Hum Genet 22:1055–1057. doi:10.1038/ejhg.2014.6
Scholtens S et al (2014) Cohort profile: lifelines, a three-generation cohort study and biobank. Int J Epidemiol. doi:10.1093/ije/dyu229
Vaught J, Lockhart N (2012) The evolution of biobanking best practices. Clin Chim Acta 413:1569–1575. doi:10.1016/j.cca.2012.04.030
Zika E et al (2011) A European survey on biobanks: trends and issues. Public Health Genomics 14:96–103
Zins M et al (2010) The CONSTANCES cohort: an open epidemiological laboratory. BMC Public Health 10:479. doi:10.1186/1471-2458-10-479
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Berr, C., Gabelle, A., Fievet, N. et al. How to optimize the use of biobanks from population-based cohorts in aging research. Biogerontology 17, 221–227 (2016). https://doi.org/10.1007/s10522-015-9586-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-015-9586-8